glp-1 metformin Emerging research suggests that medications like Ozempic and Wegovy might be beneficial for people with MS. Researchers are exploring how maintaining a healthy weight impacts MS symptoms and how drugs like GLP-1 Analogs and DeFronzo's Octet
Description
Lucey et al., 2020)

We know that patients taking GLP-1 RAs have an increased incidence of residual gastric contents even when fasting

Its part of a bigger picture that includes hormone support, sleep, and stress reduction. What the Latest Research Shows Evidence-Based and Backed by Science A 2024 study in The New England Journal of Medicine shows that patients on GLP-1 medications continued to lose weight for over a yearwith long-term maintenance when paired with expert oversight and lifestyle support

Eligibility is based on BMI of 35 or more alone, or 27 or more plus other clinical criteria

Kidney disease: Patients with diabetic kidney disease benefit from kidney protection, especially after the FLOW trial results
